Panoptes Pharma

Small molecule drugs to treat eye diseases

placeVienna, Vienna, Austria calendar_todayFounded 2013 groups5 employees language panoptes-pharma.com

Innovation

4 patent families (1 granted) — focus: Human necessities; filing pace slowing. Cited 42 times.

YearFilings
20151
20161
20173
20211

Investor mix

6 investors on record.

Investor typeCountShare
Venture capital467%
Accelerator & incubator117%
Other / undisclosed117%
Coming soon